Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
N-Acetyl Cysteine in children with autism
NCT00676195Phase 2Completed
- Sponsor
- Stanford University
- Start
- Jun 2008
- Primary completion
- Jun 2010
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of acetylcysteine in Autism Spectrum Disorder (ASD), sponsored by Stanford University. Primary endpoint: Dosage Record and Treatment Emergent Symptom Scale at 12 weeks. Started Jun 2008; status: completed.
02
Drugs
acetylcysteine
03
Conditions
Autism Spectrum Disorder (ASD)
Beyond the preview
Go deeper on NCT00676195.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00676195.